ANDREW LEE to Cost-Benefit Analysis
This is a "connection" page, showing publications ANDREW LEE has written about Cost-Benefit Analysis.
Connection Strength
0.156
-
The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
Score: 0.156
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.